Skip to main content
SpringerLink
Log in

Sertraline in 1st trimester, greater risk of congenital malformations

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Other SSRIs used during the first trimester were paroxetine, citalopram, fluoxetine and fluvoxamine. Non-SSRI antidepressants used were mainly venlafaxine and amitriptyline.

Reference

  • Berard A, et al. Sertraline Use During Pregnancy and the Risk of Major Malformations. American Journal of Obstetrics and Gynecology : [12 pages], 28 Jan 2015. Available from: URL: http://doi.org/10.1016/j.ajog.2015.01.034

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sertraline in 1st trimester, greater risk of congenital malformations. Reactions Weekly 1546, 12 (2015). https://doi.org/10.1007/s40278-015-9351-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-9351-4

Search

Navigation